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The brainstem, the ventral part of the midbrain and anterior hindbrain, contains neurons regulating 
functions, such as mood, motivation and movement. These neurons include monoaminergic cell 
types as well as neurons, including inhibitory GABAergic and excitatory glutamatergic neurons, 
associated with them. Despite its important functions, the cell types of the brainstem, and their 
developmental origins and regulation, remain poorly understood. This thesis focuses on a subtype 
of brainstem glutamatergic neuronal precursors, marked by the expression of a transcription factor 
(TF) Skor2.  
Dopaminergic and Serotonergic neurons in the anterior brainstem 
Neuromodulatory neurons using dopamine (DA) or serotonin (5-HT) as their neurotransmitter are 
present in low numbers in the brain. Roughly, two-thirds of these DA neurons are found in the 
midbrain (Niederkofler, Vera et al, 2015). The DA neurons are part of three clusters: Ventral 
Tegmental Area (VTA), Substantia Nigra pars compacta (SNpc) and the retrorubral field (RRF). 
Alongside them, the 5-HT neurons are found in the hindbrain in the raphe nuclei. Midbrain 
Dopaminergic neuron (mDA) innervate into the striatum and cortex. Other target regions include 
hippocampus, lateral Habenula, amygdala and septum. The mDA project via three pathways: 
mesostriatal/nigrostriatal, mesolimbic and mesocortical pathways. The mesostriatal pathway 
involves SN mDA neurons projecting towards the dorsal striatum. This pathway is involved in 
voluntary motor control. The mesolimbic and mesocortical pathways both involve VTA mDA 
neurons and are responsible for modulating cognition, emotion and motivation. The difference 
between these pathways is the target destination of the VTA projections. In the mesolimbic 
pathway, the VTA DA neurons project to the nucleus accumbens in the ventral striatum. 
Mesocortical pathway involves VTA DA neurons that project to the cortical regions, as the name 
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implies. In contrast, the 5-HT pathways are broader and diffusely projected throughout the rostral 
and caudal brain. The projections are less defined (Aitken et. al, 1988; Molliver et.al, 1987) in 
comparison to the mDA neurons. These projections play a part in modulating respiration, 
thermoregulation, aggression and activity.  
 
Figure 1: Anatomy of the midbrain DA and 5-HT neurons. The DA neurons effect their functions on 
the striatum, nucleus Accumbens (ventral striatum) and cortex. Their pathways are more defined in 
comparison to the 5-HT neuronal projections, which innervate most parts of the brain. (Modified 







GABAergic subtypes that play an inhibitory role in regulation of Dopaminergic and Serotonergic 
neuronal systems 
While we understand the output nature of the DA and 5-HT nuclei, the input they gather is also 
worthy of study. The local non-DA neurons, especially GABAergic and glutamatergic cells, are 
involved in the providing the input to regulate the DA-regulated processes. Below we look into a bit 
more detail on these neuronal regulation systems, starting with the GABAergic neuronal system. 
Inhibitory signals to midbrain DA (mDA) neurons are received from the GABAergic neurons located 
in the Ventral Tegmental Area (VTA), Substantia Nigra pars reticulata (SNpr) and Rostro Medial 
Tegmental nucleus (RMTg). Because of their association with dopamine neuron regulation as well 
as their proximity with the dopaminergic nuclei, these neurons were collectively coined 
dopaminergic neuron – associated GABAergic (D-GABA) neurons. Importantly, the D-GABA neuron 
subtypes share similar developmental origins and regulation in the ventral r1 (Achim et al, 2012; 
Lahti et al., 2016).  
The GABAergic neurons of the SNpr project to the thalamus and superior colliculus, controlling 
voluntary- , eye- and reward- dependent movement. These neurons are associated with the DA 
neurons of the SNpc and inhibit the DA neurons with their axon collaterals. The neuronal density is 
low in the SNpr i.e. they are sparsely distributed. They create action potential spontaneously, 
without excitatory input (Zhou et al., 2011). The inhibitory GABAergic input from the SNpr to the 
thalamus and superior colliculus inhibits activation of movement, and SNpr GABAergic neuron 
inhibition thus allows movements. The GABAergic neurons in the SNpr are divided into subgroups 
based on neurochemical markers: parvalbumin, calretinin, nitric oxide synthase, and ephrins 
(Kelsom et al., 2013). Most of the SNpr GABAergic neurons are derived from the ventral r1, whereas 
others have an anterior origin (Achim et al., 2012). These SNpr neuron subtypes also have 
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differences in the expression and function of specific transcription factors (TFs) during their 
development (Lahti et al., 2016). 
The GABAergic neurons of the RMTg are more involved in the control of phasic firing of the DA 
neurons, are activated by anterior brain regions signaling aversion, and are attached to functions 
such as motivated behavior and associative learning (Barrot et al., 2012). The RMTg GABAergic 
neurons are medium sized neurons expressing neurochemical markers, such as µ-opioid receptor, 
somatostatin and prepronociceptin. The RMTg inhibits the VTA and SNpc DA neurons during 
avoidance behavior. They also were found to express characteristic TFs (Lahti et al., 2016). 
Addictive drugs, such as opioids, cannabinoids and benzodiazepines are thought to act on the VTA 
GABAergic neurons (Morales & Margolis, 2017). The inhibitory action of the VTA GABAergic neurons 













Glutamatergic neuron subtypes in the brainstem 
The excitatory signals are provided by glutamatergic neurons and in the brainstem glutamatergic, 
neurons are found in the LDTg, IPN as well as locally in the VTA.  
Dopamine neurotransmission is of two types based on firing rate: tonic and phasic. The former is 
based on basal neuronal activity and the latter is controlled by burst firing. Burst firing is essential 
for synaptic release of DA and consequently, plays a role in the reward and goal directed behaviors. 
In Lodge and Grace (2006), it is shown tonic input from the LDTg elicits burst firing. They observed 
that inactivation led to tonic release of dopamine as seen in a pacemaker. The LDTg bears neurons 
of three types: glutamatergic, GABAergic and cholinergic (Wang and Morales, 2009). The neurons 
from this nucleus send projections to the VTA to regulate the activation as well as the firing of the 
DA neurons. Most of  these projections from the LDTg to the VTA are understood to be 
glutamatergic in nature (Lammel et al, 2012) and concurrently, optogenetic activation of the LDTg 
neurons has shown to corroborate the behavior consequences of these projections (Steidl, 2015). 
Hence, further supports the study of the LDTg and its surrounding architecture. Markers Nkx6-1 and 
Vsx2 are shown to be present in cells lateral to the DR. These cells are understood to form two 
different cell populations in the LDTg (Morello et al., 2020, Lahti et al, 2016) and consequently, are 
the markers used in this study.   
Studies have identified glutamatergic neurons in the DA nuclei, which are responsible for local 
excitatory transmission (Morales and Root, 2014). In addition, the Interpeduncular nucleus (IPN), a 
nucleus below DA and RMTg, is understood to play a role in providing excitatory input to 
monoaminergic systems such as 5-HT (Lahti et al., 2016).  The brainstem also bears glutamatergic 




Development of GABAergic and glutamatergic neurons in the ventral rhombomere 1 
Tegmental GABAergic and glutamatergic neurons mainly originate in the rhombomere 1. Some 
originate dorsally. However, GABAergic neurons of the posterior SNpr (pSNpr), VTA, and RMTg, as 
well as glutamatergic neurons in the LDTg and IPN are born in ventral r1 (Figure 2). This region bears 
molecular similarity similar to the V2 domain of the spinal cord and hence, the name rV2. In the rV2 
region, the proliferative progenitors that give rise to these neurons are marked by the expression 
of the TF Nkx6-1. The newly formed post-mitotic precursors in the rV2 are marked by distinct TFs 
i.e. GABA has Gata2, Gata3, Tal1, whereas the glutamatergic precursors express Nkx6-1 and Vsx2 
as their TFs.  The post-mitotic precursors expressing these TFs are intermixed in the rV2 regions 
close to (mx1) or more distal from (mz2) the proliferative progenitors in the ventricular zone (vz). 
These TFs push for the formation of these distinct nuclei like GABAergic SNpr and Glutamatergic 
LDTg/IPN. Thus, expression of particular TFs pushes the formation of various subtypes of GABAergic 
and glutamatergic neurons (Morello et al., 2020). However, the mechanism of how these TFs 





Figure 2. Origins of the brainstem GABAergic and glutamatergic neurons. A region of the ventral 
r1 gives rise to precursors of both GABAergic and glutamatergic neurons in brainstem nuclei 











The structure and expression of the transcription factor Skor2  
Skor2 protein is homologous to Ski/Sno family of transcriptional co-repressors. It is also known as 
FUSSEL 18 Functional Smad suppressing element on chromosome 18 (Arndt et al., 2005). Another 
name, which represents it, is Corl2, because of its resemblance to corepressor for LBX1 called Corl1 
(FUSSEL 15 - Human analog). There are two structural domains in Skor2: Daschund Homology 
Domain (DHD) and SAND domain. These two domains are also seen in Ski/Sno family proteins and 
this family is associated with negative regulation of Transforming Growth Factor – β (TGF – β)/Bone 
Morphogenic Protein (BMP) signaling pathways through SMAD binding. Because of the sequence 
similarity, Skor2 is understood to play a similar role inhibiting these pathways.  
Previous research work (Nakatani et al, 2014; Wang et al, 2011) has focused on Skor2 expression 
in the GABAergic Purkinje cells (PC) of the cerebellum. PC cells play a major role in providing the 
output from the cerebellum and is associated with functions such as movement control and 
posture. Degeneration of PCs leads to the rise of ataxic symptoms. Skor2 expression was seen in 
PC lineage cells both during the development and during adulthood. Skor2 mutants showed 
defects in cellular morphogenesis and PC maturation after birth. This suggested the Skor2 is 
essential for PC differentiation during embryonic stages. Important for my study, Skor2 was seen 
to affect GABAergic and glutamatergic phenotype in PCs (Nakatani et al, 2014). Specifically, the 
early GABAergic phenotype specification did not require Skor2, but maintenance of the GABAergic 
phenotype at later developmental stages required Skor2. At the same time, Skor2 was shown to 
suppress glutamatergic phenotype in PCs. This suggests that Skor2 could play a role as a co-




Consistent with the role of Skor2 in the PCs developing from the dorsal r1, data from single cell RNA 
sequencing of E13.5 mice has shown the presence of Skor2 transcripts in dorsal r1 -derived 
GABAergic precursors that migrate to the ventral r1 during the brainstem development (Morello et 
al., 2020). Important for this Master’s thesis work, some Skor2 expressing cells were also detected 
in the ventral r1 (rV2) - derived glutamatergic neuron precursors (Figure 3). Thus, Skor2 does not 
appear to exclusively mark GABAergic precursors. This is consistent with the expression of Skor1, a 
TF related to Skor2, both in the dorsally derived GABAergic and in the rV2 derived glutamatergic 








Figure 3: Visualization of expression of Skor2 and selected other marker genes in brainstem single 
cell mRNA sequencing data. UMAP of E13.5 mice showing the expression of Glutamatergic markers: 
Vglut2 (Slc17a6), Vsx2 (Chx10), Nkx6-1; GABAergic marker: Gad1, Skor1 (homology to Skor2) and 
Skor2. Skor2 is found in the dorsally derived GABAergic precursors (expression in the early Purkinje 
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cells derived from the dorsal rhombomere 1) and in some rV2 derived glutamatergic precursors 
(dotted box). The right side images are close-up of the area of interest (rv2 domain) for each 




















Aim 1: Characterization of Skor2 expression in the embryonic brainstem precursors and tegmental 
neurons derived from them 
Skor2 positive cells were observed in the rV2 derived glutamatergic precursor clusters in E13.5 single 
cell mRNA sequencing data. I hypothesize that Skor2 is expressed in a subset of glutamatergic 
neuronal precursors in the embryonic rV2 tissue. I also hypothesize that, at later developmental 
stages, these glutamatergic precursors move to the LDTg region. To test these hypotheses, I will 
compare the tissue distribution of Skor2 expression with glutamatergic markers Nkx6-1 and Vsx2, 
and address to what extent Skor2 is co-expressed along with these markers in the embryonic ventral 
r1 and in the mature tegmental nuclei, including the LDTg and other brainstem regions. 
  
Aim 2: Characterization of the function of Skor2 in brainstem glutamatergic neuron development 
Skor2 has been shown to regulate neuronal differentiation in other contexts. I hypothesize that 
Skor2 is important for differentiation of the rV2 derived glutamatergic neurons. To test this 
hypothesis, I will study rV2 glutamatergic precursor development and the glutamatergic brainstem 









Materials and Methods 
Mice 
The background of the mice used in this study are of the ICR strain. This strain of mouse is albino 
outbred strain and was selected at the Institute of Cancer Research, USA (Chia et al. 2005, Rice & 
Brien 1980). E0.5 is designated as the noon of the day the vaginal plug happened. The Skor2 GFP/+ 
mice were generated by introducing a green fluorescent protein (GFP) open reading frame after 
the initiation codon of the Skor2 gene. The process involves formation of a Skor2 targeting vector 
using pGFP-neo-DT-A (Figure 4). The Skor2-null mice were generated by homologous 
recombination of the Wild type ICR mice with the vector and the mutation was confirmed through 
Southern blotting. These mice express GFP at the location of Skor2 positive cells, while 
maintaining function of Skor2 repressor. Skor2 GFP/GFP homozygous knockouts were created by 
crossing the Skor2 GFP/+ heterozygous mutants with each other. These homozygote mutants were 
selected using PCR and subsequent gel electrophoresis.   
 
 
Figure 4: How the Skor2 allele is replaced with GFP. GFP cDNA in substituted instead of the Ski 
domain. Black – Coding region, White – Non-coding region. Initiation codon bears the following:  M. 





The whole embryo (E11.5-E13.5) and whole brain (E15.5, E18.5) cassettes were placed on a shaker 
with a solution of 4% PFA (paraformaldehyde) overnight. The PFA is replaced over the next two 




Tissue processing is done via Leica Biosystems Fully enclosed tissue processor. The processor 
allows the infiltration of the paraffin via treatment with various solvents. This is required as the 
wax is hydrophobic and immiscible with water. The process starts with the whole embryo/whole 
brain sample laden cassette immersed in MilliQ water and then followed by multiple changes of 
ethanol (dehydrating agent) & xylene (clearing agent). The processing is allowed to run overnight, 
which facilitates the tissue embedding the next day.  
 
Embedding 
The embryo sample is taken from the cassette and placed in a tray of hot paraffin. The sample is 
positioned to facilitate the correct angle for sectioning. Then, the cassette is placed on top and 
then whole structure is carefully moved onto a cryoplate, which is set at -1°C. This allows the 
paraffin to solidify and trap the sample in a desired position. We can separate the sample from the 




In this step, the paraffin-embedded sample is placed in a microtome and cut of shavings of the 
wax with the sample in them. These sections are then placed on adhesive slides and left overnight 
in a 32°C incubator. The slides are then taken out and placed on a heat block set at 70°C for 
around a minute. This is to remove the excess paraffin, leaving behind mostly the sample. These 
slides can be used immediately for staining or can be stored away at +4°C. Example of the cut is 
shown (dotted line) below. The purple region denotes the rhombomere1 (r1).  
 
Figure: 5. E11.5 mouse embryo (Source: Allen Mouse Brain Atlas) Dotted line represents the 








Skor2 was studied through the immunohistochemistry method. Slides are brought out from +4°C 
beforehand to let them reach room temperature before staining. 
 
Deparaffination/Rehydration  
The aim is to rehydrate the samples, so that we can return the samples back from its dormancy. This 
is done before the staining protocol, as incomplete removal of paraffin can affect staining efficiency. 
 Xylene 4 x 5 mins (the last xylene fresh each time) 
 Abs. Ethanol 3 x 2 mins (the last ethanol fresh each time) 
 94% Ethanol 2 x 2 mins 
 70% Ethanol 1 x 2 mins 
 50% Ethanol 1 x 2 mins 
 MQ 2 x 1 min 
 
Antigen retrieval 
This step allows breaking the crosslinks protecting the protein from deterioration. Crosslinks served 
their purpose earlier in storage. Now we need to return the sample to more native state by heat 
induced epitope retrieval (HIER).  
The slides were then moved to a glass tray, holding 250ml 0.01 M sodium citrate buffer pH 6.0. The 
setup was then moved to a microwave, where it was blasted at high for 3 minutes and then for 9 
minutes at a lower setting. They setup is allowed to cool down for handling, making sure not to let 
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it sit for over 30 minutes. The longer they slides are in the hot buffer, the chances are the protein 
targets may be harmed. Then the slides are washed in PBS for 5minutes on the shaker, which is then 
followed by the Permeabilization step.  
 
Permeabilization  
This step allows better penetration of the antibody solution and is performed by washing the slides 
in a detergent buffer solution of 0.3% PBST (Triton-X in PBS) for 45 minutes on the shaker. This is 
followed by just rinsing twice will MilliQ water, to get rid of the excess detergent.  
 
Blocking: 
Before adding the antibodies, we want to prevent any non – specific binding to tissue. Serum is 
generally used for such purpose and their origin is linked to which secondary antibodies are used. 
Since the secondary antibodies are from donkey, the serum is also from the same species. Here the 
slides are taken from the box and placed in a humidifying chamber to avoid drying up. 300µl of 10% 










During the blocking time, antibody dilutions are prepared in a solution of 5% donkey serum + 
0.1%Triton X-100 in PBS. The antibodies are kept on ice, while making the dilutions. The table below 
shows which antibodies were used and in what dilutions. After the dilutions were prepared, the 
blocking solution is removed from the slides. 300µl of the appropriate antibody dilutions were 
added. Above process is performed in the humidifying chamber and then left closed at 4°C over 2 
nights.  



















Rabbit GFP Abcam ab290 1:2000 
Mouse Nkx6-1 DSHB F55A10 1:1000 
Sheep Vsx2 Abcam ab16141 1:500 
Goat  ChAT Chemicon  AB144P 1:100 
Mouse  Fog2 Santa Cruz 
Biotechnology 
sc-398011 1:500 
Rabbit  FoxO1 Cell Signaling 
Technology 
mAb #2880 1:500 
Mouse TH Chemicon MAB318 1:600 
Goat 5-HT ab66047 ab66047 1:500 





After the primary antibody incubation, the slides were removed from the chamber and washed 
three times for 5 minutes in a 0.1% PBST solution, on a shaking platform. As was done before, the 
secondary antibody dilutions were prepared in DAPI+0.3% PBST (1:10000). The dilutions and the 
antibodies should be kept away from light sources, as much as possible. This is done to avoid 
bleaching of the fluorophores attached to the antibodies, which give us the fluorescence.  The 
dilutions are then added (300µl) to the slides in the chamber. The slides are kept away from light as 














Name Fluorescent dye Supplier Product code Dilution 
Donkey-anti-
mouse IgG 











































The slides were then removed from the chamber and washed in a solution of 0.1% PBST for 5 
minutes on a platform shaker. The solution is then replaced with PBS and the washes are repeated 
three times for 5 minutes each. The Slides are then mounted with coverslips using Fluorsave and 
then stored at +4°C, away from light.  
 
Imaging 
The slides were studied using Olympus BX63 Microscope (DP72 Camera) and this allowed us to take 
images from them. The images taken were merged and processed using Fiji ImageJ 1.52 (64 bit) 
 
Quantification/Cell counting and Statistical analysis 
The quantification was also done with the Fiji Image J 1.52 (64 bit), using its manual counter. The 
data was accumulated in Excel and utilized to show the data in chart form. Student t-tests were 











Skor2 is expressed in post-mitotic rV2 precursors in the mz2 along with Nkx6-1 at E11.5-E13.5  
Skor2 positive cells were seen in cell groups expressing the rV2 glutamatergic markers Nkx6-1 and 
Vsx2 in the E13.5 single cell RNA sequencing data (Morello et al., 2020). Therefore, I compared the 
expression of Skor2 and Nkx6-1 in the embryonic ventral r1 tissue. To visualize Skor2 expression, I 
used IMHC to detect GFP and Nkx6-1 expression in coronal sections of E11.5-E13.5 Skor2 GFP/+ 
embryos. I found that almost all GFP expression from the Skor2 GFP allele was in Nkx6-1 positive 
(Nkx6-1+) cells, but not all Nkx6-1+ cells expressed GFP (Figure 6). The majority of Nkx6-1 cells were 
found in the proliferative progenitors of the ventricular zone (vz) and in the post-mitotic precursors 
of the mantle zone 2 (mz2) region, while the Skor2 positive cells occupied both post mitotic mz1 and 
mz2 regions. The quantification of Skor2 positive and Skor2+Nkx6-1 double positive cells in the 









Figure 6. Analysis of the expression of Skor2 and Nkx6-1 in the rhombomere1 of early embryonic 
mouse brain 
A1-A4: E11.5, B1-B4: E12.5, C1-C4: E13.5; A1: Analysis of Skor2 and Nkx6-1 expression at E11.5. The 
square box represents the area of interest shown in A2-A4. The rV2 domain is marked with lines. 
A2: Close-up of Skor2 expression. A3: Close-up of Nkx6-1 expression. A4: Merge of Skor2 and Nkx6-
1 expression. B1: Analysis of Skor2 and Nkx6-1 expression at E12.5. The square box represents the 
area of interest shown in B2-B4. The rV2 domain is marked with lines. B2: Close-up of Skor2 
expression. B3: Close-up of Nkx6-1 expression. B4: Merge of Skor2 and Nkx6-1 markers in the area 
of interest. C1: Analysis of Skor2 and Nkx6-1 expression at E13.5. The square box represents the 
area of interest. The rV2 domain is marked with lines. C2: Close-up of Skor2 expression. C3: Close-
up of Nkx6-1 expression. C4: Merge of Skor2 and Nkx6-1 expression. DAPI is used for nuclear staining 
in all the images. Scale bar: 50 µm (The rV2 domain is indicated with a line and divided into 
ventricular zone - vz, mantle zone 1 – mz1, mantle zone – mz2) 
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Skor2  has minimal co-expression with Vsx2, the latter predominantly marking the rV2 mz1 at 
E11.5-E13.5 
Vsx2/Chx10 is another TF marking specifically the post-mitotic glutamatergic neuron precursors in 
the rV2 (Lahti et. al 2016, Morello et al., 2020, Figure 3). To analyze whether the Skor2 positive 
precursors also express Vsx2/Chx10, I performed IMHC with markers GFP and Vsx2. The GFP marker 
tags Skor2 positive cells, as the mice used were Skor2GFP/+. Analyzing the staining, I observed that 
Vsx2 positive cells were mostly confined to the mz1, whereas the Skor2 positive cells were found in 
the mz2 (Figure 7). There were some cells expressing both Vsx2 and Skor2 at the border of mz1 and 
mz2. However, in comparison to Nkx6-1, the number of double positive cells was lower. The Skor2 
positive cells were confined to the rv2 domain, as observed in the Nkx6-1 staining. Figure 8 shows 
the quantification data in the anterior and posterior brainstem of markers Skor2, Nkx6-1 and Vsx2 
together. This shows the clear difference in the number of Skor2 cells expressing Nkx6-1 more than 










Figure 7. Analysis of expression of Skor2 and Vsx2 (Chx10) in rhombomere1 of early embryonic 
mouse brain 
A1-A4: E11.5, B1-B4: E12.5, C1-C4: E13.5; A1: Analysis of Skor2 and Vsx2 expression at E11.5. The 
square box represents the area of interest shown in A2-A4. The rV2 domain is marked with lines. 
A2: Close-up of Skor2 expression. A3: Close-up of Vsx2 expression. A4: Merge of Skor2 and Vsx2 
expression. B1: Analysis of Skor2 and Vsx2 expression at E12.5. The square box represents the area 
of interest shown in B2-B4. The rV2 domain is marked with lines. B2: Close-up of Skor2 expression. 
B3: Close-up of Vsx2 expression. B4: Merge of Skor2 and Vsx2 markers in the area of interest. C1: 
Analysis of Skor2 and Vsx2 expression at E13.5. The square box represents the area of interest. The 
rV2 domain is marked with lines. C2: Close-up of Skor2 expression. C3: Close-up of Vsx2 expression. 
C4: Merge of Skor2 and Vsx2 expression. DAPI is used for nuclear staining in all the images. Scale 
bar: 50 µm (The rV2 domain is indicated with a line and divided into ventricular zone - vz, mantle 





Figure 8. Quantification of Skor2 positive and Skor2+Nkx6-1 double positive cells in E13.5 
brainstem. Skor2 positive cells versus coexpression of Skor2 and Nkx6-1 in the anterior brainstem 
(p>0.05 – Student t-test) and similar comparison between the populations in the posterior 
brainstem (p<0.05 – Student t-test). Comparison of the anterior and posterior Brainstem cell 
populations via student t-test yielded: Skor2+ve cells (p<0.05), Skor2 and Nkx6-1 double positive 
cells (p<0.05). More embryos were needed for a more quantitative analysis of Vsx2 staining. Data 









Skor2 is not expressed in the LDTg along with Nkx6-1, but shows expression in a region more 
ventral 
Next, I wanted to examine whether the Skor2 positive cells that were observed in the rv2 domain, 
would give rise to the LDTg glutamatergic neurons at the later embryonic stages. Coronal sections 
of E15.5 and E18.5 Skor2GFP/+ mice were used for IMHC with markers GFP and Nkx6-1. In contrast to 
my hypothesis, no Skor2 expression was detected in the Nkx6-1 positive LDTg neurons. Instead, the 
staining showed Skor2 positive cells occupying a distinct position more ventrally and away from the 
LDTg (Figure 9). This cluster still had a glutamatergic identity, as suggested by Nkx6-1 coexpression. 
We also the quantification data for Skor2 and Skor2+Nkx6-1 double positive cells in the brainstem 










Figure 9. Analysis of expression of Skor2 and Nkx6-1 in rhombomere1 of later embryonic mouse 
brain (E15.5 & E18.5) 
A-A6: E15.5, B1-B6: E18.5. A: Analysis of Skor2 and Nkx6-1 expression at E15.5 rhombomere1. The 
dorsal square box represents the LDTg, area of interest shown in A1-A6. A1: Close-up of Skor2 
expression. A3: Close-up of Nkx6-1 expression. A4: Merge of Skor2 and Nkx6-1 expression. The 
ventral area of interest is shown in A4-A6. A4: Close-up of Skor2 expression. A5: Close-up of Nkx6-1 
expression. A6: Merge of Skor2 and Nkx6-1 expression. B: Analysis of Skor2 and Nkx6-1 expression 
at E18.5 rhombomere1. The dorsal square box represents the LDTg, area of interest shown in A1-
A6. A1: Close-up of Skor2 expression. A3: Close-up of Nkx6-1 expression. A4: Merge of Skor2 and 
Nkx6-1 expression. The ventral area of interest is shown in A4-A6. A4: Close-up of Skor2 expression. 
A5: Close-up of Nkx6-1 expression. A6: Merge of Skor2 and Nkx6-1 expression. DAPI is used for 





 Figure 10. Quantification of Skor2 positive cells in the brainstem of E18.5 mouse.  
A: Skor2 positive cells versus co-expression of Skor2 and Nkx6-1 in the anterior (p<0.05 – Student 
t-test) and posterior brainstem cell populations (p<0.05 – Student t-test). Comparison between 
the Anterior and Posterior Brainstem cell populations via student t-test yielded: Skor2+ve cells 










Skor2 is predominantly expressed in Vsx2 negative cells at E15.5 and E18.5 
I also compared the expression of Skor2 and Vsx2 in the LDTg and other brainstem regions. This was 
done with IMHC staining of markers GFP and Vsx2. The staining showed similar results as observed 
with Nkx6-1 co-staining (Figure 11). However, the difference being the number of cells that express 
Skor2 and Vsx2 together was lower in number. The LDTg did not bear any Skor2 positive cells. Similar 
to analyses with Nkx6-1, the Skor2 positive cells were found to be in a cluster markedly lower. 
Quantification data was not available for Vsx2 costaining, due to inconsistent results with the 












Figure 11. Expression analysis of Skor2 and Vsx2 (Chx10) in rhombomere1 of E15.5 and E18.5 
mouse embryo 
A-A6: E15.5, B1-B6: E18.5. A: Analysis of Skor2 and Vsx2 expression at E15.5 rhombomere1. The 
dorsal square box represents the LDTg, area of interest shown in A1-A6. A1: Close-up of Skor2 
expression. A2: Close-up of Vsx2 expression. A3: Merge of Skor2 and Vsx2 expression. The ventral 
area of interest is shown in A4-A6. A4: Close-up of Skor2 expression. A5: Close-up of Vsx2 expression. 
A6: Merge of Skor2 and Vsx2 expression. B: Analysis of Skor2 and Vsx2 expression at E18.5 
rhombomere1. The dorsal square box represents the LDTg, area of interest shown in B1-B6. B1: 
Close-up of Skor2 expression. B2: Close-up of Vsx2  expression. B3: Merge of Skor2 and Vsx2 
expression. The ventral area of interest is shown in B4-B6. B4: Close-up of Skor2 expression. B5: 
Close-up of Vsx2 expression. B6: Merge of Skor2 and Vsx2 expression. DAPI is used for nuclear 




Anatomical characterization of Skor2 expressing cells in the posterior brainstem: identification of 
Skor2 positive neurons between the VTg and DTg 
My studies above showed that Skor2 is not expressed in the LDTg, but in a brainstem region 
ventral to it. I next wanted to define, with gene expression landmarks, the area of brainstem 
where the Skor2 expressing cells were located. The sections of the rhombomere 1 were first 
characterized using reference stains such as Tyrosine Hydroxylase (TH) and Serotonin (5-HT). 
Studies of embryos at E12.5, E15.5 and E18.5 showed that the Skor2 expressing cells end up in a 
region ventrolateral to the 5-HT positive DR and medial to the TH positive Locus coeruleus (LC) 









Figure 12. Anatomical characterization of Skor2 positive cells in comparison to cells expressing TH 
and 5-HT markers. A1 – A3: Expression profile of TH and 5-HT markers. B1 – B3: Corresponding 
expression of Skor2 A1: TH and 5-HT expression in E12.5 rhombomere 1. B1: Skor2 expression in 
relevant E12.5 embryo brainstem. A2: Expression of TH and 5-HT in rhombomere 1 of E15.5. B2: 
rhombomere 1 Skor2 expression in E15.5 embryo. A3: E18.5 rhombomere 1 expression pattern of 








Originally, we had chosen ChAT (Choline Acetyl transferase) as a marker to study the expression of 
Skor2 in cholinergic neurons of rhombomere 1. However, ChAT positive cells only show up in later 
embryonic stages and are nowhere near the Skor2 positive cells (Image not shown). Hence, ChAT 
was not an appropriate marker to study Skor2 expression in rhombomere 1. 
As we observed in the immunostaining of Skor2, the TF’s expression was observed in a region ventral 
to the LDTg. This area could be studied in comparison to other markers expressed in the region, 
namely markers expressing the in the Dorsal and the Ventral Tegmentum of Gudden (DTg and VTg). 
The DTg nucleus has cells that express FoxO1 marker and the Fog2 represents the VTg region 
(Morello et al., 2020). The appropriate sections were chosen to undergo immunostaining with the 
following sets: GFP & Fog2 and FoxO1 & Fog2. The results of these staining’s demonstrate Skor2 
expression in an area bordering both the FoxO1 and Fog2 (Figure 12). These cluster of cells are not 







Figure 12. Anatomical comparison of Skor2  positive cells with DTg (FoxO1) and VTg (Fog2) 
markers at E18.5. A1 – A3: Expression pattern of markers FoxO1 and Fog2 in E18.5 rhombomere 1. 
A1: FoxO1 expression in E18.5 rhombomere 1. A2: Fog2 expression analysis. A3: Merge of FoxO1 
and Fog2 expression. B1 – B3: Skor2  and Fog2 expression in parallel sections of same embryo. B1: 
Skor2 staining of E18.5 rhombomere 1 . B2: Fog2 expression at rhombomere 1. B3: Merge of Skor2 










Skor2 deficient mice do not seem to have changes in the brainstem cell types 
This section deals with the second part of the experiment, where I studied the effects of knocking 
out Skor2. This allows us to understand the how important Skor2 protein is for the survival of the 
brainstem neurons. Here I studied the E13.5 Skor2GFP/+ and Skor2GFP/GFP embryos side by side through 
IMHC, using markers for GFP and Nkx6-1. In the Skor2GFP allele, the Skor2 is replaced completely by 
GFP (A-A3), resulting in a functionally null allele of the gene. The GFP insertion allows us to show 
where the Skor2 expression exists and compare Skor2 expression in heterozygous and homozygous 
mutants (B-B3). As seen below, I observed no clear changes during the early embryonic stages 
between the heterozygote and the homozygote (Figure 13). This argues against an essential nature 











Figure 13. Analysis of the expression of Skor2 and Nkx6-1 in the rhombomere1 of early embryonic 
mouse brain of heterozygous and homozygous Skor2 mutants. 
A-A3: Skor2GFP/GFP E13.5. A: Analysis of Skor2 and Nkx6-1 expression at E13.5. The square box 
represents the area of interest. The rV2 domain is marked with lines. A1: Close-up of Skor2 
expression. A2: Close-up of Nkx6-1 expression. A3: Merge of Skor2 and Nkx6-1 expression. B-B3: 
Skor2GFP/+ E13.5. A: Analysis of Skor2 and Nkx6-1 expression at E13.5. The square box represents the 
area of interest. The rV2 domain is marked with lines. B1: Close-up of Skor2 expression. B2: Close-
up of Nkx6-1 expression. B3: Merge of Skor2 and Nkx6-1 expression. DAPI is used for nuclear staining 








Similarly, I studied the expression profile of Skor2 in E18.5 Skor2GFP/+ and Skor2GFP/GFP embryos 
(Figure 14). This was done by IMHC with markers GFP and Nkx6-1. The LDTg region again remained 
devoid of Skor2 presence. I detected no changes in the expression of Nkx6-1 LDTg region. 
Moreover, the ventral region of Skor2 expression between VTg and DTg was intact and expresses 
the same markers. Anatomically, the Skor2 positive cells remained in the same region. And 
similarly there did not seem ato be any changes observed with the glutamatergic marker Nkx6-1. 
This suggests the glutamatergic neurons retaining their normal function and structure. This 












Figure 14. Expression analysis of Skor2 and Nkx6-1 in rhombomere1 of E18.5 Skor2GFP/+ and E18.5 
Skor2GFP/GFP mouse embryo. 
C-C6: E18.5 Skor2 GFP/GFP, D-D6: E18.5 Skor2 GFP/+. C: Analysis of Skor2 and Nkx6-1 expression at 
E18.5 rhombomere1. The dorsal square box represents the LDTg, area of interest shown in C1-C3. 
C1: Close-up of Skor2 expression. C2: Close-up of Nkx6-1 expression. C3: Merge of Skor2 and Nkx6-
1 expression. The ventral area of interest is shown in C4-C6. C4: Close-up of Skor2 expression. C5: 
Close-up of Nkx6-1 expression. C6: Merge of Skor2 and Nkx6-1 expression. D: Analysis of Skor2 and 
Nkx6-1 expression at E18.5 Skor2 GFP/+ rhombomere1. The dorsal square box represents the LDTg, 
area of interest shown in D1-D3. D1: Close-up of Skor2 expression. D2: Close-up of Nkx6-1 
expression. D3: Merge of Skor2 and Nkx6-1 expression. The ventral area of interest is shown in D4-
D6. D4: Close-up of Skor2 expression. D5: Close-up of Nkx6-1 expression. D6: Merge of Skor2 and 
Nkx6-1 expression. DAPI is used for nuclear staining in all the images. Scale bar: 50 µm 
 






DA neurons are a vital source of Dopamine in the Central Nervous System. A defect in these neurons 
can lead to neurological disorders, including Parkinson’s disease. The DA neurons are regulated by 
GABAergic and glutamatergic neuronal systems. The GABAergic systems inhibits the firing of these 
neurons, whereas the glutamatergic neurons provide the spark or excitation for the neurons to 
perform their function. Therefore, damage to systems upstream of the DA neurons could also 
adversely affect the brain functions. Using single cell mRNA sequencing, the TF Skor2  co-expressed 
with Nkx6-1 and Vsx2 (Morello et al., 2020), TFs recently shown to mark the brainstem glutamatergic 
neurons that project to the VTA dopaminergic neurons. This thesis characterizes the expression of 
Skor2 in the embryonic brain and mature brainstem nuclei, and analyses its requirement for 
neuronal differentiation. In addition, this experiment has thrown some light towards Skor2’s 
association with glutamatergic neurons. 
 
Skor2 positive neurons label in rv2 domain of early embryonic tissues 
Results from the single cell RNA sequencing indicated the presence of Skor2 positive neurons in the 
rv2 domain of the early embryonic mouse brain. The same sequencing results suggested a close 
proximity/affinity towards glutamatergic identity for Skor2 presence. The results from my 
experiment showed that Skor2 is localized in the mantle zone 2 (mz2) area of the rv2 domain. The 
Skor2 positive cells co-stained predominantly with Nkx6-1 in the mz2, while Vsx2 positive cells near 
the mantle zone border also express Skor2. Previous research from the group (Lahti et al., 2016), 
showed that the rV2 domain was home to glutamatergic neuronal subtypes marked with Nkx6-1 
and Vsx2 expression. Thus, consistent with our hypothesis (aim1), Skor2 is expressed specifically in 
a subset of rV2 glutamatergic precursors in the developing brain. 
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Skor2 was not expressed in LDTg at later embryonic stages 
The Nkx6-1 and Vsx2 TFs are expressed in the LDTg glutamatergic neurons in the later embryonic 
stages. The early embryonic stage analyses showed that Skor2 expresses in these glutamatergic 
neurons, which in conjunction with the earlier statement, suggested that Skor2 could be expressed 
in the LDTg. However, my results show that Skor2 is not expressed in the LDTg. Instead, the Skor2 
positive cells in rhombomere1 are present in a more ventral region, but still co-express Nkx6-1 and 
Vsx2. Thus, rejecting our hypothesis (aim 1), Skor2 is not associated with the LDTg.  
 
Skor2 positive cells line up between DTg and VTg in later embryonic stages 
While studying the expression of Skor2, we observed the presence of Skor2 in a brainstem region 
with an unknown function. The area the Skor2 positive cells occupied has not been molecularly or 
anatomically well defined. Interestingly Skor2 was detected in a region between the DTg and VTg, 
with no overlap with their markers FoxO1 and Fog2 whatsoever. Both the Gudden nuclei VTg and 
DTg are dense, but project to different mammillary nucleus. This leads to different 
electrophysiological properties (Dillingham, 2015). The DTg neurons project to the lateral 
mammillary nucleus and bear head direction cells, which is lacking in the VTg. However, the VTg 
fires more in rhythm and targets the medial mammillary nucleus. The medial ‘theta’ system (S.D. 
Vann, 2009) is understood to play a vital role in memory tasks. The close proximity of the Skor2 
positive cells to the tegmental nuclei suggests there could be a possible regulatory role in controlling 





Skor2 not required for differentiation of their neuronal subtype in the embryonic development 
The other aim of the experiment was to study the importance of Skor2 to cells where it was 
expressed. To study its importance, we generated homozygous Skor2 mutants by crossing two 
heterozygote mutants (Nakatani et al., 2014). Then through immunohistochemistry, I analyzed the 
knockout with the marker Nkx6-1 at E13.5 and E18.5 stages. The Nkx6-1 marker provided very clear 
results in the heterozygote studies and hence, they were best choice to study the changes forced in 
the knockout mutant. The results in Figures 13 and 14 showed no clear distinction between the 
heterozygote Skor2GFP/+ mutant and the homozygote Skor2GFP/GFP. The rV2 domain in the early 
embryonic stage exhibited the same co-expression of the Skor2 and Nkx6-1 markers. Similarly, in 
the later embryonic stage of E18.5, the r1 looked like a facsimile of each other. This leads me to 
believe that Skor2 is not vital for the development of these nuclei in the embryonic stage. In previous 
studies, Skor2 was understood to be not required for Purkinje cell specification and maintenance of 
its cell fate (Wang et al., 2011; Nakatani et al., 2014). Thus, our study also portends to a similar belief 
regarding the cell fate of the Skor2 nuclei in the brainstem.  
 Initial design of the study included also studying the changes in comparison with Vsx2, but I had 
troubles achieving consistent signal from the Vsx2 antibody. Therefore, I focused on the Nkx6-1 
staining, which had previously shown great results and is a very good glutamatergic marker. Another 
caveat to bear in mind is that due to the time constraint of the project, we were not able study more 






Possible future experiments 
The experiment was able to answer certain questions regarding the identity of the Skor2 positive 
cells and requirements for Skor2 TF during neuronal differentiation  in the embryonic stages. To 
push on from what we learned, further studies could be directed towards certain parts in the future. 
We observed Skor2 positive cells occupying a certain cluster of cells (later embryonic stages), which 
to my knowledge have not been studied in detail before. This Skor2 neuronal cluster has been found 
to be in proximity to the DTg and the VTg nuclei. The DTg and VTg nuclei play a role in spatial learning 
& memory retention respectively. Studies regarding the Gudden tegmental nuclei could utilize the 
Skor2 cluster knowledge for reference purposes. In addition, due to their proximity, Skor2 
expressing neurons may also regulate the neurons in the VTg and DTg and thus have an impact of 
spatial learning or memory function.  
I could not demonstrate a requirement for Skor2 during neuronal differentiation. Skor1 is another 
member of the Ski family as Skor2. They are both transcriptional corepressors and both express in 
rV2 glutamatergic precursors (Morello et al., 2020). Hence, it raises the question of why both? Do 
they have different roles pertaining to different conditions? The redundancy being a possible point 
of confusion. To bring clarity, we could study the effect on neuronal differentiation in double mutant 
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